Takuya Minagawa

International University of Health and Welfare

Papers

Total Citations

H-Index

About

Takuya Minagawa is a leading figure in the surgical oncology of biliary tract cancer (BTC), with a focused expertise in advancing minimally invasive surgery (MIS) for complex hepatobiliary malignancies. His major contributions center on critically evaluating the oncological safety and technical feasibility of laparoscopic and robotic approaches for BTC, including distal bile duct and hilar cholangiocarcinoma resections. In his seminal review, "Essential Updates 2023/2024: Minimally Invasive Surgery for Biliary Tract Cancer," Minagawa synthesizes the latest evidence to clarify the uncertain oncological impact of MIS in this challenging field. While his most-cited work currently holds 1 citation—reflecting its very recent publication—his research is poised to shape clinical guidelines and surgical decision-making. Minagawa’s work is notable for bridging the gap between emerging technology and rigorous oncological principles, offering a balanced perspective that prioritizes patient outcomes over procedural novelty. For students and researchers, his profile exemplifies how a surgeon-scientist can drive innovation while maintaining a critical, evidence-based approach to cancer care.